Showing codes J2320 (Injection, nandrolone decanoate, up to 50 mg) — J2427 (Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg)

J2320 - Nandrolone decanoate 50 mg
Long description: Injection, nandrolone decanoate, up to 50 mg
Code added date: 19860101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2323 - Natalizumab injection
Long description: Injection, natalizumab, 1 mg
Code added date: 20080101.
Code effective date: 20080101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2325 - Nesiritide injection
Long description: Injection, nesiritide, 0.1 mg
Code added date: 20060101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2326 - Inj, nusinersen, 0.1mg
Long description: Injection, nusinersen, 0.1 mg
Code added date: 20180101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2327 - Inj risankizumab-rzaa 1 mg
Long description: Injection, risankizumab-rzaa, intravenous, 1 mg
Code added date: 20230101.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2329 - Inj ublituximab-xiiy, 1 mg
Long description: Injection, ublituximab-xiiy, 1mg
Code added date: 20230701.
Code effective date: 20230701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2350 - Injection, ocrelizumab, 1 mg
Long description: Injection, ocrelizumab, 1 mg
Code added date: 20180101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2353 - Octreotide injection, depot
Long description: Injection, octreotide, depot form for intramuscular injection, 1 mg
Code added date: 20040101.
Code effective date: 20040101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2354 - Octreotide inj, non-depot
Long description: Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg
Code added date: 20040101.
Code effective date: 20040101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2355 - Oprelvekin injection
Long description: Injection, oprelvekin, 5 mg
Code added date: 19990101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2356 - Inj tezepelumab-ekko, 1mg
Long description: Injection, tezepelumab-ekko, 1 mg
Code added date: 20220701.
Code effective date: 20220701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2357 - Omalizumab injection
Long description: Injection, omalizumab, 5 mg
Code added date: 20050101.
Code effective date: 20050101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2358 - Olanzapine long-acting inj
Long description: Injection, olanzapine, long-acting, 1 mg
Code added date: 20110101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2359 - Inj. olanzapine, 0.5mg
Long description: Injection, olanzapine, 0.5 mg
Code added date: 20231001.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2360 - Orphenadrine injection
Long description: Injection, orphenadrine citrate, up to 60 mg
Code added date: 19820101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2370 - Phenylephrine hcl injection
Long description: Injection, phenylephrine hcl, up to 1 ml
Code added date: 19820101.
Code effective date: 20230701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2371 - Inj phenylephrine hcl 20 mcg
Long description: Injection, phenylephrine hydrochloride, 20 micrograms
Code added date: 20230701.
Code effective date: 20230701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2372 - Inj, biorphen, 20 micrograms
Long description: Injection, phenylephrine hydrochloride (biorphen), 20 micrograms
Code added date: 20230701.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2373 - Inj, immphentiv, 20 mcg
Long description: Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms
Code added date: 20240701.
Code effective date: 20240701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2400 - Chloroprocaine hcl injection
Long description: Injection, chloroprocaine hydrochloride, per 30 ml
Code added date: 19860101.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2401 - Chloroprocaine hcl injection
Long description: Injection, chloroprocaine hydrochloride, per 1 mg
Code added date: 20230101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2402 - Chloroprocaine (clorotekal)
Long description: Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg
Code added date: 20230101.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2403 - Chloroprocaine opht gel, 1mg
Long description: Chloroprocaine hcl ophthalmic, 3% gel, 1 mg
Code added date: 20230401.
Code effective date: 20230401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2404 - Inj, nicardipine 0.1 mg
Long description: Injection, nicardipine, 0.1 mg
Code added date: 20240101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2405 - Ondansetron hcl injection
Long description: Injection, ondansetron hydrochloride, per 1 mg
Code added date: 19930101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2406 - Injection, oritavancin 10 mg
Long description: Injection, oritavancin (kimyrsa), 10 mg
Code added date: 20211001.
Code effective date: 20211001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2407 - Injection, oritavancin
Long description: Injection, oritavancin (orbactiv), 10 mg
Code added date: 20160101.
Code effective date: 20211001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2410 - Oxymorphone hcl injection
Long description: Injection, oxymorphone hcl, up to 1 mg
Code added date: 19820101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2425 - Palifermin injection
Long description: Injection, palifermin, 50 micrograms
Code added date: 20060101.
Code effective date: 20060101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2426 - Inj, invega sustenna, 1 mg
Long description: Injection, paliperidone palmitate extended release (invega sustenna), 1 mg
Code added date: 20110101.
Code effective date: 20230701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2427 - Inj, invega hafyera/trinza
Long description: Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg
Code added date: 20230701.
Code effective date: 20230701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF